Category Archives: BioEngineering

Photo by: L. Brian Stauffer/UI

Rashid Bashir

CHAMPAIGN Rashid Bashir, a professor and the department head of bioengineering at the University of Illinois, will be the permanent executive associate dean at The Carle Illinois College of Medicine.

In that position, Bashir will work alongside Dean King Li to direct and oversee development and operations at the Carle Illinois College of Medicine, the nation's first engineering-based college of medicine. The appointment will be effective Aug. 16, pending approval by the UI Board of Trustees.

"Professor Bashir is a pioneering researcher at the interface of medicine and engineering as well as a respected leader on our campus," said UI interim Provost John Wilkin. "He has been a key player in developing the unique mission and curriculum of the Carle Illinois College of Medicine since its inception. His passion for education and proven record of innovation exemplify the visionary ambitions of this new college and make him the perfect choice to serve as the executive associate dean."

Bashir's research focuses on integrating engineering and technology with biology, from the molecular scale to tissues and systems. Among other innovations, his group has developed various lab-on-a-chip technologies, miniature biological robots and point-of-care diagnostic devices, leading to the creation of three startup companies.

Bashir earned a Ph.D. in electrical engineering from Purdue University in 1992. He has served in multiple leadership roles since joining the Illinois faculty in 2007, acting as the director of the Micro and Nano Technology Laboratory from 2007-13 and as the head of bioengineering since 2013.

He has played a large role in the development of the Carle Illinois College of Medicine as chairman of the curriculum committee and as the interim vice dean. The college, a partnership between the UI and Carle Health System, will enroll its first class of students in 2018.

Read the original:
UI bioengineering head named as med school's executive associate dean - Champaign/Urbana News-Gazette

An interdisciplinary team of researchers has developed technology that enables a smartphone to perform lab-grade medical diagnostic tests that typically require large, expensive instruments.

Costing only $550 USD, the spectral transmission-reflectance-intensity (TRI)-Analyzer was spearheaded by bioengineering and electrical and computer engineering professor Brian Cunningham at the University of Illinois. The device attaches to a smartphone and analyzes patient blood, urine, or saliva samples as reliably as clinic-based instruments that cost thousands of dollars.

"Our TRI Analyzer is like the Swiss Army knife of biosensing," said Cunningham. "It's capable of performing the three most common types of tests in medical diagnostics, so in practice, thousands of already-developed tests could be adapted to it."

In a recently published paper, Cunningham's team used the TRI Analyzer to perform two commercially available assaysa test to detect a biomarker associated with pre-term birth in pregnant women and the PKU test for newborns to indirectly detect an enzyme essential for normal growth and development. Their tests results were comparable to those acquired with clinic-grade spectrometer instrumentation.

"The TRI Analyzer is more of a portable laboratory than a specialized device," said Kenny Long, an MD/PhD student and lead author of the research study.

Among the many diagnostic tests that can be adapted to their point-of-care smartphone format, Long said, is an enzyme-linked immunosorbent assay (ELISA), which detects and measures a wide variety of proteins and antibodies in blood and is commonly used for a wide range of health diagnostics tests.

The system is capable of detecting the output of any test that uses a liquid that changes color, or a liquid that generates light output (such as from fluorescent dyes).

The TRI Analyzer operates by converting the smartphone camera into a high-performance spectrometer. Specifically, the analyzer illuminates a sample fluid with the phone's internal white LED flash or with an inexpensive external green laser diode.

The light from the sample is collected in an optical fiber and guided through a diffraction grating into the phone's rear-facing internal camera. These optical components are all arranged within a 3D-printed plastic cradle.

The TRI Analyzer can simultaneously measure multiple samples by using a microfluidic cartridge that slides through an opening in the back of the cradle. This ability to analyze multiple samples quickly and reliably makes the Analyzer suitable for patients who lack convenient access to a clinic or hospital with diagnostic test facilities or for patients with urgent health situations requiring rapid results.

"Our Analyzer can scan many tests in a sequence by swiping the cartridge past the readout head, in a similar manner to the way magnetic strip credit cards are swiped," said Long.

In addition to its applications in health diagnostics, Cunningham said the TRI Analyzer can also be applied to point-of use applications that include animal health, environmental monitoring, drug testing, manufacturing quality control, and food safety. The patented technology is available for license.

For more smartphone modifications, find out how the T3D Smartphone 3D Printer Could Democratize 3D Printing.

The rest is here:
Add-On Turns Smartphones into Tricorders - ENGINEERING.com

Its been nearly a decade since the doors to WPIs Life Sciences and Bioengineering Center (LSBC) opened. The first building to rise at Gateway Park, an 11-acre mixed-use campus taking shape just north of downtown Worcester and a short walk from the main WPI campus, the LSBC, formally dedicated on September 17, 2007, represented something of a gamble. In building the 125,000-square-foot research facility, the university was betting that by making a $65 million investment in the life sciences (the cost of the building and the site clean-up), it would realize dividends down the road.

That bet has paid off, and then some, says Eric Overstrm, former professor of biology and biotechnology, who joined WPI in 2004 as head of that department. This building has produced a return on investment well beyond anything we anticipated at the time, he says.

The LSBC was the answer to a question that had been nagging at WPI since it acquired the Gateway Park property in 1999, jointly with the Worcester Business Development Corporation: How could that former industrial brownfield benefit the university? The idea of constructing a building to provide much-needed space for a growing a research enterprise emerged early on, but what kind of research would be represented was unclear.

Overstrm recalls a meeting where several faculty members described the facilities they envisioned for the new center, including fire labs and a drop tower for impact research. He and his fellow life sciences department heads, the late Chris Sotak in Biomedical Engineering and Jim Dittami in Chemistry and Biochemistry, huddled and decided to propose a more focused approach: move all of WPIs graduate research programs in the life sciences and bioengineering to the new building.

The idea had a practical motivation. The wet labs in the 115-year-old Salisbury Laboratories building, where the biologist and biomedical engineers worked, were poorly suited to modern research, while lab space in the newer Goddard Hall, home to chemistry, biochemistry, and chemical engineering research, was running short as the WPI faculty grew.

Continued here:
How One Building Created a Cascade of Change - WPI News

Worldwide Bioreactors and Fermenters Market 2017 presents a widespread and fundamental study of Bioreactors and Fermenters industry along with the analysis of subjective aspects which will provide key business insights to the readers. Global Bioreactors and Fermenters Market 2017 research report offers the analytical view of the industry by studying different factors like Bioreactors and Fermenters market growth, consumption volume, market trends and Bioreactors and Fermenters industry cost structures during the forecast period from 2017 to 2022.

Bioreactors and Fermenters market studies the competitive landscape view of the industry. The Bioreactors and Fermenters report also includes development plans and policies along with manufacturing processes. The major regions involved in Bioreactors and Fermenters Market are (United States, EU, China, and Japan).

For Sample Copy Of The Report Click Here: https://market.biz/report/global-bioreactors-and-fermenters-market-2017/94290/#inquiry

Leading Manufacturers Analysis in Global Bioreactors and Fermenters Market 2017:

1 Sartorius AG ?BBI?2 Thermo Fisher3 Merck KGaA4 GE Healthcare5 Danaher (Pall)6 Eppendorf AG7 Praj Hipurity Systems8 Pierre Guerin (DCI-Biolafitte)9 ZETA10 Applikon Biotechnology11 Bioengineering AG12 Infors HT13 Solaris14 Other

Bioreactors and Fermenters Market: Type Segment Analysis

Single-use BioreactorsMultiple-use Bioreactors

Bioreactors and Fermenters Market: Applications Segment Analysis

Biopharmaceutical CompaniesCROsAcademic and Research InstitutesOthers

The Bioreactors and Fermenters report does the thorough study of the key industry players to understand their business strategies, annual revenue, company profile and their contribution to the global Bioreactors and Fermenters market share. Diverse factors of the Bioreactors and Fermenters industry like the supply chain scenario, industry standards, import/export details are also mentioned in Global Bioreactors and Fermenters Market 2017 report.

Key Highlights of the Bioreactors and Fermenters Market:

A Clear understanding of the Bioreactors and Fermenters market based on growth, constraints, opportunities, feasibility study.

Concise Bioreactors and Fermenters Market study based on major geographical regions.

Analysis of evolving market segments as well as a complete study of existing Bioreactors and Fermenters market segments.

Discover More About Report Here: https://market.biz/report/global-bioreactors-and-fermenters-market-2017/94290/

Furthermore, distinct aspects of Bioreactors and Fermenters market like the technological development, economic factors, opportunities and threats to the growth of Bioreactors and Fermenters market are covered in depth in this report. The performance of Bioreactors and Fermenters market during 2017 to 2022 is being forecasted in this report.

In conclusion, Global Bioreactors and Fermenters market 2017 report presents the descriptive analysis of the parent market based on elite players, present, past and futuristic data which will serve as a profitable guide for all the Bioreactors and Fermenters industry competitors.

Excerpt from:
2017-2022 Global Bioreactors and Fermenters Market Analysis : Applikon Biotechnology , Bioengineering AG , Infors ... - First Newshawk

People Aug 08, 2017 Share

Metro Planning, Nashville Fire Department, Silverado Records, Vanderbilt announce updates

The Nashville Fire Department has hired Joseph Pleasant as public information officer.

He come to the department after seven years as a reporter and anchor at WKRN News Channel 2

Prior to his stint at WKRN, Pleasant also worked as a reporter in both Monroe, Louisiana, and Jackson, Mississippi.

Pleasant (pictured) attended Texas A&M University, graduating with a degree in journalism and psychology. He then attended graduate school at Northwestern University where he obtained a master's degree in journalism.

Metro Planning welcomes return of Jones

The Metro Planning Department has added Lee Jones as manager of community plans and design studio

Jones (click on the above photo to see an image) most recently served for 11 years as owner of Common Ground Urban Planning + Design (formerly Third Coast Design Studio). From 2001 to 2006, he worked with the planning department.

Jones holds a masters degree in landscape architecture from Mississippi State University. He received his B.A. degree in political science at the University of Southern Mississippi.

VU Miga tapped to NIH center section

Vanderbilt University professor Michael Miga has been appointed to serve a four-year term on the Bioengineering, Technology, and Surgical Sciences Study Section of the National Institutes of Health Center for Scientific Review.

Miga (click on the above photo to see an image) is the Harvie Branscomb Professor and VU professor of biomedical engineering, radiology and radiological sciences, and neurological surgery. He is director of the Biomedical Modeling Laboratory, one of 10 affiliated labs within the Vanderbilt Institute for Surgery and Engineering. He is a co-founder of VISE.

The BTSS Study Section reviews grant applications in the interdisciplinary fields of surgery and bioengineering to develop innovative medical instruments, materials, processes, implants, and devices to diagnosis and treat disease and injury. Within BTSS there is a balance between basic, translational, and clinical research and application and development of emerging cross-cutting technologies relevant to surgical systems.

Silverado Records announces two personnel moves

Nashville-based Silverado Records has announced that Marketing Director Heather Cramsie will now serve as Partnerships Director for Exegan Media & Entertainment, Silverados parent company.

Cramsie has also taken on the official role of A&R Director for the newly re-launched rock label Poison Tree Records.

In addition, Silverado Records' Administrative Assistant Kaylie Thomas has been promoted to Marketing Coordinator for the label.

Send personnel information to wwilliams@nashvillepost.com or selliott@nashvillepost.com

View post:
On the Move: 8 August 2017 - Nashville Post (subscription)

Jennifer Cochran, PhD, has been appointed chair of Stanfords Department of Bioengineering, which is jointly operated by the School of Medicine and School of Engineering. Her five-year term begins Sept. 1.

This department has an amazing energy due in no small part to its faculty, students and staff, said Cochran, associate professor of bioengineering. These individuals nearly 500 of them, in all have an unwavering commitment to research, learning and service, and they exude a spirit of collegiality and collaboration that permeates our department and the broader Stanford community.

Cochrans research is interdisciplinary, integrating chemistry, engineering and biophysics. Her laboratory focuses on protein-based drug discovery for applications including oncology and regenerative medicine, and the development of new technology for high-throughput protein analysis and engineering.

In addition to being a superb scholar and educator and a proponent of deeper connections with Silicon Valleys burgeoning biotechnology activities, Jennifer is an enthusiastic, dynamic individual who will bring exciting leadership to the department and be a key contributor to the schools of Engineering and Medicine, Lloyd Minor, MD, dean of the School of Medicine, and Jennifer Widom, PhD, dean of the School of Engineering, said in a joint statement.

Cochran will succeed Norbert Pelc, ScD, professor of bioengineering, who has chaired the department since 2012. Norberts vision and leadership has brought the department to new heights, Minor and Widom said. The remarkable strength of our still relatively new Bioengineering Department reflects Norberts tireless work and deep dedication.

Cochran earned a PhD in biological chemistry from the Massachusetts Institute of Technology in 2001. After a postdoctoral fellowship at MIT in biological engineering, she arrived at Stanford in 2005 as an assistant professor of bioengineering. In 2012,she was promoted to associate professor.She also advises cancer biology and biophysics graduate students and serves as director of the Stanford National Institutes of Health Biotechnology Predoctoral Training Program and as co-director of the Stanford National Institute of Standards and Technology Predoctoral Training Program.

Continue reading here:
Jennifer Cochran appointed chair of bioengineering - Stanford Medical Center Report